CELL & gene THERAPY steering committee
Mission
To build and advance the supply chain of this nascent medical science by
- promoting collaboration among the emerging stakeholders;
- creating a platform for exchange of business knowledge and experience;
- fostering commercialization and scaling up of CAR-T Cell Therapy;
- incorporating agility, accountability, quality and integrity in the business end-to-end;
- and enabling the delivery of affordable healthcare in the long run.
The Supply Chain challenges are truly Draconian with the production batch size of one, where the environment of temperature control, chain of custody, overall product and process integrity, and reliability of supply of manufacturing materials is demanding. It is an unprecedented challenge for science and business to come together.
Join Steering Committees
Co-Chairpersons

Venkat Yepuri
Coo, Immpact

Colby Voorhees
Sr. Director, Global Life Sciences, Slalom

Heather Erickson
Former Vice President, Global Supply Chain, Sangamo

Dr. Alison Moore
Member of the Board, Artiva Biotherapeutics

Bernard Huyghe
Director, External Supply, Allogene Therapeutics

Matthew Yedwabnick, Sr.
Former Vice President, Operations, Atara Biotherapeutics

Franck Toussaint
Managing Director, Biolog Europe

Kenneth Locke
Vice President, Manufacturing, Carisma Therapeutics

Kimberly Foster
Scientific Director, Bristol Myers Squibb

David Karakas
Sr. Director, Strategic Sourcing and Procurement, Tessera Therapeutics

Jayant Aphale
Vice President, Technical Operations, aTyr Pharma

Neil Ackerman
Senior Director, Enterprise Supply Chain Global Planning and Innovation, Johnson and Johnson

Deidre Hobbs
Senior Director, Quality, Kite Pharma

Howard Bland, Sr.
Director, Sourcing & Procurement, Kite Pharma

Sophia-Donaldson
Head Global Strategic Sourcing, Kite Pharma

Reggie Foster
Sr. Director, Sourcing & Procurement, Kite Pharma

Kirstin Powell
Vice President Quality Assurance, Talaris

Peter Holman
Vice President, Supply Chain, Aresenal Bio

Ran Zheng
CEO, Landmark Bio

Heather Steinmetz
QA Manager for Bone Marrow Transplant, UCLA

Robert Bottome
Retd. Head of Global Supply Chain, BioMarin

Aileen Baquiran
SVP, Operations, Landmark Bio

Jon Miller
Director, Head of Supply Chain, Wugen

Mandar Paralkar, Sr.
Director and Digital Innovation Advisor of Life Sciences, SAP

Jon Pieter Kapelle
Vice President of Strategy, 4G Clinical

Kevin Cast
Partner, Archbow Consulting (Omnicom Health Group)

Paul Furgal
Vice President, Archbow Consulting (Omnicom Health Group)

Greg Bodnar, Sr.
Manager, Client Engagement, BeTheMatch

Bob Lamont
Partner, Clark Consulting

Carlo Guy
Indepenent Consultant

Carla Reed
CEO, New Creed

Chris Bogart
Vice President of Supply Chain, Bayer Healthcare
2019 Conference Documents
Notes from 0814 Meeting
OPERATIONS–THE GATEWAY TO SUCCESS IN CELL AND GENE THERAPIES
Navigating the Unique Manufacturing Challenges in Cell and Gene Therapy
Commercial Considerations for Planning a Successful Cell and Gene Therapy Product Launch
Overcoming Complexities of the Personalized Medicine Supply Chain
2018 Conference Documents

